Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · IEX Real-Time Price · USD
105.25
-0.21 (-0.20%)
At close: May 31, 2024, 4:00 PM
105.15
-0.10 (-0.10%)
After-hours: May 31, 2024, 6:56 PM EDT

Jazz Pharmaceuticals Revenue

Jazz Pharmaceuticals had revenue of $3.84B in the twelve months ending March 31, 2024, with 2.81% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $901.98M with 1.03% year-over-year growth. In the year 2023, Jazz Pharmaceuticals had annual revenue of $3.83B with 4.78% growth.

Revenue (ttm)
$3.84B
Revenue Growth
+2.81%
P/S Ratio
1.73
Revenue / Employee
$1,372,634
Employees
2,800
Market Cap
6.63B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.83B174.83M4.78%
Dec 31, 20223.66B565.14M18.26%
Dec 31, 20213.09B730.67M30.91%
Dec 31, 20202.36B201.81M9.34%
Dec 31, 20192.16B270.84M14.32%
Dec 31, 20181.89B272.23M16.82%
Dec 31, 20171.62B130.72M8.79%
Dec 31, 20161.49B163.17M12.32%
Dec 31, 20151.32B151.93M12.95%
Dec 31, 20141.17B300.45M34.44%
Dec 31, 2013872.42M286.44M48.88%
Dec 31, 2012585.98M313.70M115.21%
Dec 31, 2011272.28M98.50M56.68%
Dec 31, 2010173.78M45.33M35.29%
Dec 31, 2009128.45M60.94M90.26%
Dec 31, 200867.51M2.21M3.39%
Dec 31, 200765.30M20.45M45.58%
Dec 31, 200644.86M23.41M109.20%
Dec 31, 200521.44M--
Dec 31, 20040--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
The Ensign Group 3.85B
Acadia Healthcare Company 2.99B
Masimo 1.98B
Exelixis 1.85B
HealthEquity 999.59M
Intra-Cellular Therapies 513.93M
Legend Biotech 342.80M
Blueprint Medicines 282.21M
Revenue Rankings